{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:57:11Z","timestamp":1790528231031,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Rep."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Primary central nervous system lymphoma (PCNSL) can be differentiated from glioblastoma multiforme (GBM) using positron emission tomography (PET) with [\n                      <jats:sup>18<\/jats:sup>\n                      F]fluoro-2-deoxy-D-glucose (FDG). However, differentiation is often difficult with magnetic resonance imaging (MRI) or FDG PET alone. We have used various PET tracers to aid glioma diagnosis; here, we assessed whether multiple PET tracers improve the distinction between GBM and PCNSL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We studied 148 patients with newly diagnosed brain tumors: 96 with GBM and 52 with PCNSL (according to the 2016 World Health Organization classification). Tumor-to-normal tissue ratios (TNRs) were calculated for FDG, L[methyl[\n                      <jats:sup>11<\/jats:sup>\n                      C]]methionine, and 3\u2032deoxy3\u2032[\n                      <jats:sup>18<\/jats:sup>\n                      F]fluorothymidine (FLT). Tumor-to-blood ratio (TBR) was measured for [\n                      <jats:sup>18<\/jats:sup>\n                      F]fluoromisonidazole (FMISO).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median FDG TNR was 1.52 (interquartile range [IQR], 1.13\u20132.13) for GBM and 2.89 (IQR, 1.95\u20133.85) for PCNSL. MET TNR was 6.38 (IQR, 4.68\u20137.48) for GBM and 4.01 (IQR, 3.28\u20137.52) for PCNSL. FLT TNR was 17.35 (IQR, 11.10\u201322.28) for GBM and 25.61 (IQR, 15.91\u201355.30) for PCNSL. FMISO TBR was 2.72 (IQR, 2.22\u20133.62) for GBM and 1.58 (IQR, 1.04\u20131.93) for PCNSL. Receiver operating characteristic analysis showed areas under the curve of 0.78 (FDG), 0.62 (MET), 0.69 (FLT), and 0.85 (FMISO). FLT TNR had the highest sensitivity of 83.2% while FMISO TBR had the highest specificity of 84.2%. Among the four tracers, FLT showed the highest sensitivity and FMISO showed the highest specificity. Dual\u2011tracer combinations did not improve overall diagnostic accuracy beyond the best single tracers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among four PET tracers, FMISO was most effective in distinguishing GBM from PCNSL. Diagnostic accuracy was highest when each tracer was used individually.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41824-026-00302-x","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:27:46Z","timestamp":1777588066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of various positron emission tomography tracers in differentiating primary central nervous system lymphoma from glioblastoma multiforme"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1793-2073","authenticated-orcid":false,"given":"Nobuhiko","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"1","key":"302_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3892\/or.2022.8457","volume":"49","author":"L Cao","year":"2022","unstructured":"Cao L, Zhang M, Zhang Y, Ji B, Wang X, Wang X (2022 Dec 8) Progress of radiological\u2011pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high\u2011grade glioma (review). Oncol Rep 49(1):20. https:\/\/doi.org\/10.3892\/or.2022.8457","journal-title":"Oncol Rep"},{"key":"302_CR2","unstructured":"Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L et al Imaging proliferation in brain tumors with 18 F-FLT PET: comparison with 18 F-FDG. Report"},{"key":"302_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/hematolrep16040072","volume-title":"The role of 11C-Methionine PET imaging for the evaluation of Lymphomas: a systematic review. Hematology reports","author":"F Dondi","year":"2024","unstructured":"Dondi F, Gazzilli M, Vigan\u00f2 GL, Pisani AR, Ferrari C, Rubini G et al (2024) The role of 11C-Methionine PET imaging for the evaluation of Lymphomas: a systematic review. Hematology reports. Multidisciplinary Digital Publishing Institute (MDPI), pp 752\u2013768. https:\/\/doi.org\/10.3390\/hematolrep16040072"},{"issue":"6","key":"302_CR4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/infdis\/170.6.1394","volume":"170","author":"C Flexner","year":"1994","unstructured":"Flexner C, van der Horst C, Jacobson MA, Powderly W, Duncanson F, Ganes D, Barditch-Crovo PA, Petty BG, Baron PA, Armstrong D, Bricmont P, Kuye O, Yacobi A, Desjardins R, Polsky B (1994 Dec 1) Relationship between plasma concentrations of 3\u2019-deoxy-3\u2019-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. The J Infect Dis 170(6):1394\u20131403. https:\/\/doi.org\/10.1093\/infdis\/170.6.1394","journal-title":"The J Infect Dis"},{"issue":"4","key":"302_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","volume":"40","author":"AWJM Glaudemans","year":"2013","unstructured":"Glaudemans AWJM, Enting RH, Heesters MAAM, Dierckx RAJO, van Rheenen RWJ, Walenkamp AME, Slart RHJA (2013 Apr) Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imag 40(4):615\u2013635. https:\/\/doi.org\/10.1007\/s00259-012-2295-5","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"13","key":"302_CR6","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.7150\/jca.54952","volume":"12","author":"M He","year":"2021","unstructured":"He M, Zhang W, Wang J, Gao L, Jiao L, Wang L, Zheng J, Cai Z, Yang J (2021) Aggregative perivascular tumor cell growth pattern of primary central nervous system Lymphomas is associated with hypoxia-related endoplasmic Reticulum stress. J Cancer 12(13):3841\u20133852. https:\/\/doi.org\/10.7150\/jca.54952","journal-title":"J Cancer"},{"issue":"1","key":"302_CR7","doi-asserted-by":"publisher","first-page":"015005","DOI":"10.1117\/1.NPh.9.1.015005","volume":"9","author":"SPC Hsu","year":"2022","unstructured":"Hsu SPC, Hsiao TY, Pai LC, Sun CW (2022 Jan) Differentiation of primary central nervous system lymphoma from glioblastoma using optical coherence tomography based on attention ResNet. Neurophoton. 9(1):015005. https:\/\/doi.org\/10.1117\/1.NPh.9.1.015005","journal-title":"Neurophoton."},{"issue":"6","key":"302_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s11307-010-0447-1","volume":"13","author":"Y Kawase","year":"2011","unstructured":"Kawase Y, Yamamoto Y, Kameyama R, Kawai N, Kudomi N, Nishiyama Y (2011 Dec) Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma. Mol Imag Biol 13(6):1284\u20131289. https:\/\/doi.org\/10.1007\/s11307-010-0447-1","journal-title":"Mol Imag Biol"},{"issue":"6","key":"302_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","volume":"37","author":"ST Lee","year":"2007","unstructured":"Lee ST, Scott AM (2007 Nov) Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. Semin Nucl Med 37(6):451\u2013461. https:\/\/doi.org\/10.1053\/j.semnuclmed.2007.07.001","journal-title":"Semin Nucl Med"},{"issue":"6","key":"302_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016 Jun) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"8","key":"302_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021 Aug 2) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncology"},{"issue":"1","key":"302_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11060-023-04534-w","volume":"166","author":"T Norikane","year":"2024","unstructured":"Norikane T, Mitamura K, Yamamoto Y, Manabe Y, Murao M, Arai-Okuda H, Hatakeyama T, Miyake K, Nishiyama Y (2024 Jan) Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. J Neurooncol 166(1):195\u2013201. https:\/\/doi.org\/10.1007\/s11060-023-04534-w","journal-title":"J Neurooncol"},{"issue":"2","key":"302_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00259-012-2275-9","volume":"40","author":"A Shinomiya","year":"2013","unstructured":"Shinomiya A, Kawai N, Okada M, Miyake K, Nakamura T, Kushida Y, Haba R, Kudomi N, Yamamoto Y, Tokuda M, Tamiya T (2013 Jan) Evaluation of 3\u2032-deoxy-3\u2032-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas. Eur J Nucl Med Mol Imag 40(2):175\u2013185. https:\/\/doi.org\/10.1007\/s00259-012-2275-9","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"6","key":"302_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3174\/ajnr.A3383","volume":"34","author":"CH Toh","year":"2013","unstructured":"Toh CH, Wei KC, Chang CN, Ng SH, Wong HF (2013 Jun) Differentiation of primary central nervous system Lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol 34(6):1145\u20131149. https:\/\/doi.org\/10.3174\/ajnr.A3383","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"302_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MNM.0000000000001510","volume":"43","author":"S Uchinomura","year":"2022","unstructured":"Uchinomura S, Mitamura K, Norikane T, Yamamoto Y, Oishi A, Hatakeyama T, Miyake K, Nishiyama Y (2022 Mar 1) Distinguishing between primary central nervous system lymphoma and glioblastoma using [18F]fluoromisonidazole and [18F]FDG PET. Nucl Med Commun 43(3):270\u2013274. https:\/\/doi.org\/10.1097\/MNM.0000000000001510","journal-title":"Nucl Med Commun"},{"issue":"6","key":"302_CR16","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cyto.b.21641","volume":"94","author":"van der Meulen M","year":"2018","unstructured":"van der Meulen M, Bromberg JEC, Lam KH, Dammers R, Langerak AW, Doorduijn JK, van der Meulen M, Kros JM, van den Bent MJ, van der Velden VHJ (2018 Nov 1) Flow cytometry shows added value in diagnosing lymphoma in brain biopsies. Cytometry Part B Clin 94(6):928\u2013934. https:\/\/doi.org\/10.1002\/cyto.b.21641","journal-title":"Cytometry Part B Clin"},{"key":"302_CR17","doi-asserted-by":"publisher","first-page":"935459","DOI":"10.3389\/fneur.2022.935459","volume":"13","author":"G Zhang","year":"2022","unstructured":"Zhang G, Li J, Hui X (2022) Use of 18F-FDG-PET\/CT in differential diagnosis of primary central nervous system lymphoma and high-grade gliomas: a meta-analysis. Front Neurol 13:935459. https:\/\/doi.org\/10.3389\/fneur.2022.935459","journal-title":"Front Neurol"},{"key":"302_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejrad.2018.04.020","volume":"104","author":"W Zhou","year":"2018","unstructured":"Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Geng D, Guan Y (2018 Jul) 18F-FDG PET\/CT in immunocompetent patients with primary central nervous system lymphoma: differentiation from glioblastoma and correlation with DWI. Eur J Radiol 104:26\u201332. https:\/\/doi.org\/10.1016\/j.ejrad.2018.04.020","journal-title":"Eur J Radiol"},{"issue":"25","key":"302_CR19","doi-asserted-by":"publisher","first-page":"41518","DOI":"10.18632\/oncotarget.17456","volume":"8","author":"Y Zou","year":"2017","unstructured":"Zou Y, Tong J, Leng H, Jiang J, Pan M, Chen Z (2017 Jun 20) Diagnostic value of using 18F-FDG PET and PET\/CT in immunocompetent patients with primary central nervous system lymphoma: a systematic review and meta-analysis. Oncotarget 8(25):41518\u201341528. https:\/\/doi.org\/10.18632\/oncotarget.17456","journal-title":"Oncotarget"}],"container-title":["EJNMMI Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-026-00302-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-026-00302-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-026-00302-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:55:16Z","timestamp":1781650516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41824-026-00302-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1186\/s41824-026-00302-x","relation":{},"ISSN":["3005-074X"],"issn-type":[{"value":"3005-074X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All analyses involving human participants complied with the ethical standards of the Institutional Research Committee at Kagawa University Faculty of Medicine the principles enshrined in the Declaration of Helsinki (2013 amendment) or comparable ethical standards. The requirement for informed consent was waived due to the retrospective study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}